Peptide Pen Prostamax (KEDP 20mg Prefilled Pen)

Prostamax (KEDP) is a short-chain synthetic peptide supplied in a pre-reconstituted prefilled pen format for controlled dispensing. It belongs to the class of bioregulator peptides and is investigated for its role in cellular signalling and tissue-specific regulatory pathways.

Prostamax has been studied in experimental models for its interaction with biological processes related to prostate tissue and broader cellular regulatory systems.

Key Features:

• 20mg Prostamax (KEDP: lysine–glutamic acid–aspartic acid–proline) per prefilled pen

• Approx. multi-dose pen format (dose increments dependent on pen system)

• Prefilled pen for controlled and consistent application

• Investigated for roles in cellular and tissue-specific signalling pathways

• Studied in relation to prostate-related biological processes

• Associated in research with cellular regulation and maintenance pathways

Suggested Use:
For research or controlled professional use only. Protocols vary depending on study design and should be determined by qualified professionals in an appropriate setting.

Storage:

• Store at 2–8°C at all times (refrigerated)

• Do not freeze

• Protect from light

• Avoid repeated temperature fluctuations

• Maintain sterile handling and use within a limited timeframe once in use

Important Information:
Prostamax is an investigational peptide with limited large-scale human clinical data available and is not widely approved for general use. Intended for use within appropriate research or professional frameworks. Not recommended for individuals under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Ensure compliance with applicable regulations prior to use.